stars 1 stars 2 stars 3

Geroa Diagnostics is a clinical-stage In Vitro Diagnostics company developing a novel salivary diagnostic biomarker for Alzheimer’s Disease (AD). Our patent-protected biomarker addresses the key unmet needs in AD diagnostics including being a low cost, non-invasive, technique that is well-suited to disseminated community-based testing.

GEROA DIAGNOSTICS Questions

Melanie Pinheiro Malheiro is the Directora de Desarrollo de Negocio of GEROA DIAGNOSTICS.

2 people are employed at GEROA DIAGNOSTICS.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users